Filter Results:
(3,188)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,385)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,961)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,385)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,961)
- February 2021 (Revised March 2022)
- Case
TikTok in 2020: Super App or Supernova?
By: Jeffrey F. Rayport, Dan Maher and Dan O'Brien
TikTok’s parent company, ByteDance, was launched in 2012 around a simple idea – helping users entertain themselves on their smartphones while on the Beijing Subway. In less than a decade, it had become one of the world’s most valuable private companies, with investors... View Details
Keywords: Business Model; Business Startups; Business Organization; Change Management; Disruption; Cross-Cultural and Cross-Border Issues; Global Strategy; Health Pandemics; Innovation Strategy; Growth and Development Strategy; Growth Management; Brands and Branding; Marketing Strategy; Marketing Channels; Network Effects; Digital Platforms; Product Design; Product Development; Partners and Partnerships; Opportunities; Social Issues; Mobile and Wireless Technology; Internet and the Web; Value Creation; United States; China
Rayport, Jeffrey F., Dan Maher, and Dan O'Brien. "TikTok in 2020: Super App or Supernova?" Harvard Business School Case 821-087, February 2021. (Revised March 2022.)
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Pharmaceutical Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- December 2004 (Revised April 2014)
- Case
Stan Lapidus: Profile of a Medical Entrepreneur
By: Robert F. Higgins and Sophie LaMontagne
Describes the career path and insights of Stanley Lapidus, a successful serial entrepreneur in the medical and life sciences industry. Lapidus is the founder of Cytyc Corp. (NASDAQ: CYTC) and EXACT Sciences (NASDAQ: EXAS) and is currently the CEO of his third start-up,... View Details
Keywords: Business Startups; Experience and Expertise; Entrepreneurship; Venture Capital; Managerial Roles; Health Industry
Higgins, Robert F., and Sophie LaMontagne. "Stan Lapidus: Profile of a Medical Entrepreneur." Harvard Business School Case 805-087, December 2004. (Revised April 2014.)
- 28 Mar 2016
- Blog Post
Why I Chose to Pursue an MD/MBA at Harvard
post-baccaluareate program before starting at Harvard Medical School. The first year of medical school we took a health care policy class - we are one of the few medical schools to have a formal policy course that is required. The class... View Details
- 18 Jun 2018
- Research & Ideas
Warning: Scary Warning Labels Work!
Marketers can make a bottle of sugar water look like golden elixir. Can health advocates sour the taste for consumers? (SteveDF) San Francisco is in a three-year battle with the American Beverage Industry... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
breakthrough in] the biotech industry takes a lot of time; it takes a lot of money; it's complicated science." And it takes a lot of people—from scientists to executives to board members. Bancel admits that people see the potential fairly... View Details
- 20 May 2022
- Blog Post
Nucleate Eco: Connecting Aspiring MBA Entrepreneurs with Cutting Edge Climate Research
resistant plants, novel biofuels processes, and alternative meat production. This year we’ve further expanded and even have a few non-life sciences teams in our cohort, working on industrial waste recycling and recyclable packaging... View Details
- 2014
- Working Paper
Management Practices, Relational Contracts and the Decline of General Motors
By: Susan Helper and Rebecca Henderson
General Motors was once regarded as one of the best managed and most successful firms in the world, but between 1980 and 2009 its share of the US market fell from 62.6 to 19.8 percent, and in 2009 the firm went bankrupt. In this paper we argue that the conventional... View Details
Keywords: Organizational Change and Adaptation; Management Practices and Processes; Organizational Structure; Decision Making; Insolvency and Bankruptcy; Manufacturing Industry; Manufacturing Industry
Helper, Susan, and Rebecca Henderson. "Management Practices, Relational Contracts and the Decline of General Motors." Harvard Business School Working Paper, No. 14-062, January 2014. (NBER Working Paper Series, No. 19867, January 2014.)
- 12 Nov 2019
- Research & Ideas
Corporate Innovation Increasingly Benefits from Government Research
sponsored by government agencies, such as the National Science Foundation (NSF) or the National Institutes of Health (NIH). “Previously, it was possible to figure out what patents came directly out of government research labs,” Yao says.... View Details
Keywords: by Michael Blanding
- 15 Jan 2013
- First Look
First Look: January 15
circumscribe citizen-employees, and they engage in production and trade. But individual corporations are no longer adequate to serve as the primary unit of analysis. Over the years, systems of distributed innovation-so-called business ecosystems-have become... View Details
Keywords: Sean Silverthorne
- November 2022 (Revised April 2024)
- Case
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At the time, there was little medication... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Pharmaceutical Industry; Pharmaceutical Industry; United States; District of Columbia
Spar, Debora L., and Julia M. Comeau. "Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams." Harvard Business School Case 323-039, November 2022. (Revised April 2024.)
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide... View Details
Keywords: Opioids; Drug; Investors; Shareholder Activism; Investment Activism; Executive Compensation; Corporate Accountability; Corporate Governance; Governance Compliance; Governance Controls; Risk Management; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Business and Stakeholder Relations; Legal Liability; Distribution Industry; Distribution Industry; Distribution Industry; United States; West Virginia; Tennessee; Ohio; Pennsylvania
Srinivasan, Suraj, and Li-Kuan Ni. "The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen." Harvard Business School Case 122-014, October 2021. (Revised October 2022.)
- 08 Mar 2016
- First Look
March 8, 2016
OIG to become an integral part of the company's open innovation journey. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/616035-PDF-ENG Harvard Business School Case 815-054 The Development of the Markets for Natural, Organic, and View Details
Keywords: Sean Silverthorne
- 08 Mar 2022
- Blog Post
Recalling My First Cold Call: A Conversation with Second-Year Students
2022) Halperin, a student in the MS/MBA: Engineering Sciences Program, is the co-president of the Harvard Business School (HBS) Women’s Student Association, social chair of the MS/MBA program, and the international representative of section H. She is also a member of... View Details
- August 2005 (Revised May 2007)
- Case
Partners Healthcare
By: Joshua D. Coval
Focuses on the portfolio allocation decision of a passive fund manager. Provides a setting to study portfolio theory, including mean-variance analysis, the capital market line, and the efficient frontier. View Details
Keywords: Investment Portfolio; Capital Markets; Business or Company Management; Decisions; Health Industry
Coval, Joshua D. "Partners Healthcare." Harvard Business School Case 206-005, August 2005. (Revised May 2007.)
- November 2021
- Case
The Wolf in Cashmere: LVMH's Bid to Acquire Tiffany
By: Stuart C. Gilson and Sarah L. Abbott
In November 2019, the iconic U.S. jeweler Tiffany agreed to be acquired by the luxury goods conglomerate LVMH. The $16.6 billion transaction was scheduled to close in mid-2020. However, in 2020, the global COVID-19 pandemic took a toll on the luxury goods sector. In... View Details
Keywords: Mergers ＆ Acquisitions; Luxury Brand; COVID-19 Pandemic; Mergers and Acquisitions; Health Pandemics; Lawsuits and Litigation; Consumer Products Industry; United States; Europe
Gilson, Stuart C., and Sarah L. Abbott. "The Wolf in Cashmere: LVMH's Bid to Acquire Tiffany." Harvard Business School Case 222-054, November 2021.
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
Keywords: Product Development; Marketing Strategy; Health Testing and Trials; Risk and Uncertainty; Technological Innovation; Innovation Strategy; Science-Based Business; Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- September 2020 (Revised February 2021)
- Case
Zameer Kassam Fine Jewelry: Engaging Clients
By: Ryan W. Buell and Amy Klopfenstein
Zameer Kassam Fine Jewelry (ZKFJ) designs custom engagement rings that tell the story of a couple’s relationship. The case describes the company’s process for engaging clients, which has historically been a relatively offline, high-touch experience. Obliged by... View Details
Keywords: Customer Engagement; Service Delivery; Health Pandemics; Internet and the Web; Customer Satisfaction; Organizational Change and Adaptation; Growth and Development; Retail Industry
Buell, Ryan W., and Amy Klopfenstein. "Zameer Kassam Fine Jewelry: Engaging Clients." Harvard Business School Case 621-043, September 2020. (Revised February 2021.)
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details
Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- Web
Sexual Harassment - Race, Gender & Equity
leadership. *Controlling for age, race, marital/partner status, industry, sector, and size of company. By Industry, Last 3 Years In four of the five industries where HBS alumni are most likely to work, half or more of alumnae experienced... View Details